The growing disparity between clinical trial complexity and investigator compensation
dc.contributor.author | Burgess L.J. | |
dc.contributor.author | Sulzer N.U. | |
dc.date.accessioned | 2011-05-15T16:15:52Z | |
dc.date.available | 2011-05-15T16:15:52Z | |
dc.date.issued | 2010 | |
dc.description.abstract | [No abstract available] | |
dc.description.version | Editorial | |
dc.identifier.citation | Cardiovascular Journal of Africa | |
dc.identifier.citation | 21 | |
dc.identifier.citation | 5 | |
dc.identifier.issn | 19951892 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/13527 | |
dc.subject | budget | |
dc.subject | cardiovascular disease | |
dc.subject | clinical research | |
dc.subject | compensation | |
dc.subject | drug industry | |
dc.subject | editorial | |
dc.subject | food and drug administration | |
dc.subject | human | |
dc.subject | risk factor | |
dc.subject | South Africa | |
dc.subject | Budgets | |
dc.subject | Clinical Trials as Topic | |
dc.subject | Costs and Cost Analysis | |
dc.subject | Humans | |
dc.subject | Research Support as Topic | |
dc.subject | South Africa | |
dc.title | The growing disparity between clinical trial complexity and investigator compensation | |
dc.type | Editorial |